PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the supportive care and treatment of cancer patients, today announces the resignation of Gilles Avenard MD. as Board Member and Deputy Chief Executive Officer, in charge of R&D.
